← Back to Newsletter Archive

Greetings!

Welcome to the Monthly QPS Preclinical Newsletter


We invite you to explore QPS Leukopak Services, discover our Central Safety Lab Service and stay ahead of the curve by catching up on the latest breakthroughs and insights on the QPS blog.

Leukopaks - an Essential Tool in the Development of Cell Therapies

Unlock the full potential of your research and drug development projects with QPS leukopak services. By partnering with QPS, you gain access to meticulously collected and processed leukopaks, ensuring the highest standards of purity and viability.


Let us support your business in advancing medical breakthroughs and achieving your research goals.

Contact QPS Today

Learn More about QPS Leukopak Services 

High-Quality Leukopaks and Cell Products from QPS

QPS Central Safety Lab

QPS, your trusted partner for safety testing in clinical trials, offers a full suite of on-site safety lab testing solutions ensuring that your clinical trials are compliant, accurate, and efficient.

 

We understand that on-site safety testing is critical in clinical trials, and our experienced team ensures your trials proceed smoothly with the highest standards of accuracy and compliance.


Learn More about Our Central Safety Lab

Discover the Future of Science on the QPS Blog

Gene Therapy Targets Mitochondria to Destroy Cancer Cells


Scientists have designed a new gene therapy strategy that uses an optogenetic approach to attack cancer cells from the inside. Optogenetics combines genetic engineering and light to control cell functions by introducing light-sensitive proteins into target cells...


Short-Circuiting the Cell’s Power Supply

More Cell & Gene Therapy Blog Posts

Breaking Ground in Cancer Treatment: First T-Cell Therapy Approved for Solid Tumors


Tecelra®, the first engineered T-cell therapy for solid tumors, has received approval from the Food and Drug Administration (FDA) for advanced MAGE-A4+ synovial sarcoma in adults with specific human leukocyte antigen…


Pioneering a New Approach

Explore the QPS Ultimate Guide to Gene Therapy

Subscribe to the QPS Blog

Visit our website www.qps.com 

or contact us at info@qps.com

for an appointment.

Linkedin  Youtube  Twitter  Facebook  

www.qps.cominfo@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive